BNP Paribas Corporate & Investment Banking (CIB) has decided to help in the global fight against infectious diseases by joining forces with the Institut Pasteur, a long-time partner of the BNP Paribas Foundation. BNP Paribas CIB will offer financial aid across 29 countries to medical research teams from the International Network of Instituts Pasteur as well as to laboratories working in collaboration with the Institut Pasteur in Paris.
The chosen research programs include dengue fever (Mexico), hepatitis C (Spain), the measles and HIV vaccines (United Kingdom), amoebiasis diagnosis (India), malaria (Colombia and Brazil), West Nile virus (Czech Republic), tuberculosis (Belgium) and avian flu (France) ….
Local example of our support
“We share the international scope and the values of excellence, innovation and quality set by projects supported by the Institut Pasteur around the world,” said Jacques d’Estais, Head of BNP Paribas Corporate & Investment Banking. “That is why we are proud to support such projects and contribute to the advancement of medical research. As a major international company, we consider this commitment to be an integral part of our responsibility as global citizens.”
Alice Dautry, Director General of the Pasteur Institute, expressed her gratitude at this generous contribution to the fight against infectious diseases. “For 120 years sponsorship has played a major role in the Institut’s development. The loyal support given by BNP Paribas and its Foundation to our researchers is part of this tradition. It also bears witness to the excellent relationship developed between our two organizations over the years and to the importance that BNP Paribas places on public health issues.”
About BNP Paribas CIB
BNP Paribas Corporate and Institutional Banking (CIB) has almost 16,000 employees deployed in over 53 countries around the world. BNP Paribas excels in three fundamental sectors in particular:
Derivatives – it is one of the leading global players in rates, credit, forex, commodity and equity derivatives.
Capital markets – it is amongst the top ten Euro houses for both ECM and DCM (bond issues, securitization, convertibles and shares).
Structured finance – it is amongst the world leaders for acquisition, export, project and commodity finance.
The Institut Pasteur, awarded the title of 2008 Cause of National Importance (Grande Cause Nationale 2008), is a private, non-profit foundation recognized for its public benefit. Its mission is to contribute towards the prevention and treatment of diseases through research, teaching and public health initiatives.
Since its foundation in 1888, the Institut Pasteur has focused on these three principal vocations that lie in the public interest. While remaining faithful to the humanist spirit of its founder, Louis Pasteur, the Institut’s biomedical research center has always been at the forefront of science and has been the source of several major areas of research. Birthplace of microbiology, the center has also contributed to the creation of the fundamentals of immunology and molecular biology. It is original both as a private foundation and in its presence throughout the world. The International Network of the Instituts Pasteur spans on five continents, making this institution a unique global entity. Over its 120-year existence, the quality of the Institut’s research has been recognized by being awarded 10 Nobel prizes.
Press contact :
Pascal Hénisse +33 140 14 65 14 / email@example.com